Home > Insider Trading > Filing (0001213900-11-005740)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
838879	Radient Pharmaceuticals Corp	RXPC	Pharmaceutical Preparations (2834)	330413161

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1140358	Anstalt Capital Alpha	Pradafant 7 Furstentums 9490 Vaduz N2		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-10-27	1,400,000	$0.01	8,742,312	No	4	S	Direct
Common Stock	Disposition	2011-10-28	5,052,094	$0.01	3,690,218	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common	Convertible Notes	$0.00	2011-05-24	2011-09-24	60,766,202	60,766,202	Direct
Common	Warrants	$0.28	2009-11-30	2016-12-10	207,668	207,688	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2011-09-24	60,766,202	60,766,202	Direct
2016-12-10	207,668	207,688	Direct

Footnotes

On August 25, 2011, the Issuer and Alpha entered into a Final Settlement Agreement that superceded the Settlement Agreement dated May 23, 2011, as amended, and in which the parties acknowledged that as of August 2, 2011, Alpha was no longer deemed an affiliate of the Issuer.
The Final Settlement Agreement, the Notes and the Warrants contain "blocker" provisions designed to prevent Alpha from being a beneficial owner of more than 9.99% of the Issuer's outstanding common stock.